000 01540 a2200409 4500
005 20250515093935.0
264 0 _c20080219
008 200802s 0 0 eng d
022 _a1365-2249
024 7 _a10.1111/j.1365-2249.2007.03541.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, L-Y
245 0 0 _aLevamisole enhances immune response by affecting the activation and maturation of human monocyte-derived dendritic cells.
_h[electronic resource]
260 _bClinical and experimental immunology
_cJan 2008
300 _a174-81 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnthelmintics
_xtherapeutic use
650 0 4 _aCells, Cultured
650 0 4 _aDendritic Cells
_xdrug effects
650 0 4 _aFlow Cytometry
650 0 4 _aHLA-DR Antigens
_ximmunology
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_ximmunology
650 0 4 _aInterleukin-10
_ximmunology
650 0 4 _aInterleukin-12 Subunit p40
_ximmunology
650 0 4 _aLevamisole
_xtherapeutic use
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aLymphocyte Culture Test, Mixed
650 0 4 _aMAP Kinase Signaling System
_xdrug effects
650 0 4 _aStimulation, Chemical
650 0 4 _aTh1 Cells
_ximmunology
650 0 4 _aToll-Like Receptor 2
_ximmunology
700 1 _aLin, Y-L
700 1 _aChiang, B-L
773 0 _tClinical and experimental immunology
_gvol. 151
_gno. 1
_gp. 174-81
856 4 0 _uhttps://doi.org/10.1111/j.1365-2249.2007.03541.x
_zAvailable from publisher's website
999 _c17522198
_d17522198